DE69130586T2 - Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten - Google Patents

Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten

Info

Publication number
DE69130586T2
DE69130586T2 DE69130586T DE69130586T DE69130586T2 DE 69130586 T2 DE69130586 T2 DE 69130586T2 DE 69130586 T DE69130586 T DE 69130586T DE 69130586 T DE69130586 T DE 69130586T DE 69130586 T2 DE69130586 T2 DE 69130586T2
Authority
DE
Germany
Prior art keywords
treatment
prostaglandin
keto
derivatives
pancreatic disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69130586T
Other languages
English (en)
Other versions
DE69130586D1 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of DE69130586D1 publication Critical patent/DE69130586D1/de
Application granted granted Critical
Publication of DE69130586T2 publication Critical patent/DE69130586T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69130586T 1990-05-01 1991-04-29 Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten Expired - Lifetime DE69130586T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11613990 1990-05-01

Publications (2)

Publication Number Publication Date
DE69130586D1 DE69130586D1 (de) 1999-01-21
DE69130586T2 true DE69130586T2 (de) 1999-06-17

Family

ID=14679704

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130586T Expired - Lifetime DE69130586T2 (de) 1990-05-01 1991-04-29 Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten

Country Status (7)

Country Link
US (1) US5164415A (de)
EP (1) EP0455448B1 (de)
KR (1) KR970005174B1 (de)
AT (1) ATE174221T1 (de)
CA (1) CA2041417C (de)
DE (1) DE69130586T2 (de)
TW (1) TW209170B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
ES2310013T3 (es) * 1997-11-28 2008-12-16 Sucampo Ag Uso de compuestos de 15-ceto-prostaglandina e como antagonistas de endotelina.
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
CZ303625B6 (cs) * 1999-10-15 2013-01-16 Sucampo Ag Stabilní farmaceutický prostredek obsahující bicyklickou slouceninu a acyglycerol, bicyklická sloucenina, zpusob stabilizace bicyklické slouceniny, farmaceutický prostredek obsahující bicyklickou slouceninu
ATE433754T1 (de) * 2000-04-06 2009-07-15 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
CN1273140C (zh) * 2001-05-18 2006-09-06 苏坎波公司 导泻组合物
WO2003030912A1 (en) * 2001-08-31 2003-04-17 Sucampo Ag Prostaglandin analogs as chloride channel opener
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
CA2510051C (en) * 2002-12-27 2016-07-05 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
US20060073328A1 (en) * 2004-09-21 2006-04-06 Andover Coated Products, Inc. Strapping system with non-elastic cohesive tape
EP1803809A3 (de) * 2005-08-12 2007-12-19 Abgenomics Corporation Modulation des Peroxisomen-Proliferatoren-Aktivierten Rezeptors
US8026393B2 (en) 2006-01-24 2011-09-27 Sucampo Ag Soft-gelatin capsule formulation
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
KR101950386B1 (ko) 2018-12-26 2019-02-20 성신여자대학교 연구 산학협력단 15-케토 프로스타글란딘 e2를 유효성분으로 포함하는 암 치료용 약학 조성물
CN114450337B (zh) * 2019-09-30 2023-10-24 株式会社普利司通 橡胶组合物、橡胶-金属复合体、输送带、软管、履带、和轮胎

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58203911A (ja) * 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Also Published As

Publication number Publication date
DE69130586D1 (de) 1999-01-21
EP0455448A3 (en) 1992-07-08
CA2041417A1 (en) 1991-11-02
KR910019620A (ko) 1991-12-19
KR970005174B1 (ko) 1997-04-14
CA2041417C (en) 2002-05-21
TW209170B (de) 1993-07-11
ATE174221T1 (de) 1998-12-15
EP0455448A2 (de) 1991-11-06
US5164415A (en) 1992-11-17
EP0455448B1 (de) 1998-12-09

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69024744T2 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
DE69123892D1 (de) Behandlung von Katarakt mit prostacyclinverbindungen
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE69001988D1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH